5th Australasian Vaccines & Immunotherapeutics Development Meeting.
AVID 2014 will provide a forum to discuss emerging concepts in vaccine design and immunotherapeutic drug development, spanning from basic mechanisms to translation and commercialisation.
Burnet’s malaria specialists, Professor Brendan Crabb and Professor James Beeson will be presenting on Day 2, Thursday 8 May in the Malaria session.
HIV researcher and clinician, Professor Sharon Lewin is part of the HIV session on Day 3, Friday 9 May,
Also presenting is Professor Eric Gowans on Adjuvants and Dendritic Cells on Wednesday, 7 May.
Invited Plenary Speakers include:
- Associate Professor Julie Blander, Mount Sinai Hospital, USA
- Professor Adrian Hill, The Jenner Institute, USA
- Professor Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
- Dr Juliana McElrath, University of Washington, USA
- Dr Raman Rao, Head external R&D, Asia Pacific, Sanofi Pasteur, Singapore
- Associate Professor Brian Rudd, Cornell University, USA
- Professor Federica Sallusto, Institute for Research in Biomedicine, Switzerland
- Dr Allan Saul, Novartis Vaccines Institute for Global Health, Italy.
Among the themes highlighted at AVID 2014 are:
- Effector Memory Immune Cells and Vaccination
- Novel Vaccines – Dendritic Cells, T Cells
- Therapeutic Antibodies
- Emerging Infectious Diseases – Challenges and Solutions
- Innate Immunity
- Chronic Infections
- Commercialisation of Vaccine and Immunotherapeutic Drugs.
Register online at www.avid2014.org.